In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s002800051021PMID 10854134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vinflunine (20′,20′-difluoro- 3′,4′-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro

  2004cited by this paper
• Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts.

  1999cited by this paper
• Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines

  1998cited by this paper
• Disruption of p53 function in immortalized human cells does not affect survival or apoptosis after taxol or vincristine treatment.

  1998cited by this paper
• The effect of combining antitubulin agents on differentiated and undifferentiated human colon cancer cells

  1998cited by this paper
• A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity.

  1998cited by this paper
• Mutation of the p53 gene in human astrocytic tumours correlates with increased resistance to DNA-damaging agents but not to anti-microtubule anti-cancer agents.

  1998cited by this paper
• Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.

  1998cited by this paper
• Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid

  1998cited by this paper
• In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines

  1998cited by this paper
• New antimetabolites in cancer chemotherapy and their clinical impact.

  1998cited by this paper
• Vinca Alkaloids in Superacidic Media: A Method for Creating a New Family of Antitumor Derivatives

  1997cited by this paper
• New developments in antitumor anthracyclines.

  1997cited by this paper
• Vinorelbine (Navelbine): a third-generation vinca alkaloid.

  1997cited by this paper
• In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines.

  1997cited by this paper
• A Checkerboard Method to Evaluate Interactions Between Drugs

  1996cited by this paper
• A checkerboard method to evaluate interactions between drugs.

  1996cited by this paper
• Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro

  1996cited by this paper
• Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

  1996cited by this paper
• Vinorelbine: a novel vinca alkaloid.

  1995cited by this paper
• The search for synergy: a critical review from a response surface perspective.

  1995cited by this paper
• Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.

  1994cited by this paper
• New vinca alkaloids and related compounds.

  1992cited by this paper
• The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

  1991cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• Topoisomerase-targeting antitumor drugs.

  1989cited by this paper
• Antitumor effect of two-drug simultaneous or sequential use of cisplatin, vindesine or etoposide on human pulmonary adenocarcinoma cell lines in tumor clonogenic assay.

  1986cited by this paper
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

  1984influential reference
• Short communicationsFurther biological activities of vincaleukoblastine—an alkaloid isolated from Vinca rosea (L.)

  1959cited by this paper

• Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells

  2024cites this paper
• Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells

  2024cites this paper
• Green Approaches for Cancer Management: an Effective Tool for Health Care.

  2021cites this paper
• Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane

  2018cites this paper
• Investigations on Antioxidant, Antiproliferative and COX‐2 Inhibitory Potential of Alkaloids from Anthocephalus cadamba (Roxb.) Miq. Leaves

  2017cites this paper
• Vinflunine for the treatment of non-small cell lung cancer

  2016cites this paper
• (19)F applications in drug development and imaging - a review.

  2014cites this paper
• A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

  2014cites this paper
• Cinnamaldehyde/chemotherapeutic agents interaction and drug-metabolizing genes in colorectal cancer.

  2014cites this paper
• Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction

  2013cites this paper
• Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.

  2012cites this paper
• Enhancement of Anticancer Efficacy of Chemotherapeutics by Gambogic Acid Against Gastric Cancer Cells

  2012cites this paper
• A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes

  2012cites this paper
• A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

  2011cites this paper
• Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy.

  2011cites this paper
• Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review

  2011cites this paper
• Vinflunine: review of a new vinca alkaloid and its potential role in oncology

  2011influential citation
• Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.

  2010cites this paper
• Three-dimensional gastric cancer cell culture using nanofiber scaffold for chemosensitivity test.

  2009cites this paper
• A systematic review of the efficacy and safety of fluoridation

  2008cites this paper
• Vinflunine in the treatment of bladder cancer

  2008cites this paper
• Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, in vitro

  2008cites this paper
• Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors.

  2008cites this paper
• Antitumor activity of vinflunine: effector pathways and potential for synergies.

  2008cites this paper
• Vinflunine: A New Microtubule Inhibitor Agent

  2008cites this paper
• Chemotherapeutic options for cisplatin-ineligible patients with advanced carcinoma of the urothelium.

  2008cites this paper
• Novel cytotoxic drugs: old challenges, new solutions.

  2008cites this paper
• Vinflunine: clinical perspectives of an emerging anticancer agent

  2008influential citation
• Herpes Simplex Virus-based gene Therapy Enhances the Efficacy of Mitomycin-C in the Treatment of Human Bladder Transitional Cell Carcinoma

  2008cites this paper
• Phase II study of vinflunine in malignant pleural mesothelioma.

  2007cites this paper
• Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines

  2007cites this paper
• Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapy

  2006cites this paper
• Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro

  2006cites this paper
• [Vinflunine: a new anti-cancer fluorinated agent derived from Vinca-alkaloids].

  2005cites this paper
• Vinflunine: a novel antitubulin agent in solid malignancies

  2005cites this paper
• La vinflunine, nouvel agent anticancéreux fluoré dérivé des alcaloïdes de Vinca

  2005cites this paper
• Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.

  2005cites this paper
• Synergistic interaction between platinum-based antitumor agents and demethylcantharidin.

  2005cites this paper
• Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.

  2004cites this paper
• Vinflunine.

  2004cites this paper
• Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.

  2004cites this paper
• Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity.

  2004cites this paper
• Vinflunine potentiates the activity of cisplatin but not 5-fluorouracil in a transplantable murine adenocarcinoma model.

  2003cites this paper
• Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours.

  2003cites this paper
• Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel fluorinated epipodophylloid.

  2002cites this paper
• Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10min infusion every 3 weeks in patients with advanced solid tumours

  2002cites this paper
• Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder.

  2002cites this paper
• Vinorelbine

  2002cites this paper
• Schedule-dependent interaction between vinblastine and cisplatin in Ehrlich ascites tumors in mice.

  2002influential citation
• Synergistic effects of F 11782, a novel dual inhibitor of topoisomerases I and II, in combination with other anticancer agents

  2002cites this paper
• Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers.

  2001cites this paper
• Vinflunine, the latest Vinca alkaloid in clinical development. A review of its preclinical anticancer properties.

  2001cites this paper
• Open Access Journal of Urology Dovepress Critical Evaluation of Vinflunine in the Treatment of Refractory Metastatic Urothelial Carcinoma

  year unknowncites this paper